PBE Among Technology ETFs
End-of-day Nov 17, 2026 · 58 Technology ETFs by 1M
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.1% | −3.9% | −1.1% | −2.6% | +17.8% | +25.0% | +81.5% | +34.4% | +158.4% | +435.5% |
| Peer average | −1.3% | −4.4% | −9.3% | −12.6% | +1.7% | +3.4% | +64.5% | +20.7% | +365.7% | — |
| S&P 500 · VOO | −1.0% | −2.4% | −4.5% | −4.5% | +8.3% | +10.2% | +72.7% | +68.0% | +305.1% | — |
$59 of every $1,000 in PBE is Regeneron
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | REGNRegeneron Pharmaceuticals | Healthcare | 5.88% | $588.13 | 26K | $25.0M |
| 2 | BIIBBiogen | Healthcare | 5.87% | $586.84 | 99K | $25.0M |
| 3 | GILDGilead Sciences | Healthcare | 5.80% | $579.88 | 147K | $24.7M |
| 4 | RPRXRoyalty Pharma | Healthcare | 5.68% | $568.32 | 353K | $24.2M |
| 5 | AMGNAmgen | Healthcare | 5.38% | $538.20 | 50K | $22.9M |
| 6 | VRTXVertex Pharmaceuticals | Healthcare | 5.01% | $500.74 | 40K | $21.3M |
| 7 | ILMNIllumina | Healthcare | 4.53% | $453.02 | 97K | $19.3M |
| 8 | NTRANatera | Healthcare | 4.41% | $441.07 | 65K | $18.8M |
| 9 | MRNAModerna | Healthcare | 3.81% | $380.57 | 75K | $16.2M |
| 10 | VCELVericel | Healthcare | 3.73% | $373.44 | 276K | $15.9M |
| 11 | EXELExelixis | Healthcare | 3.32% | $332.19 | 211K | $14.1M |
| 12 | QGENQiagen | Healthcare | 3.20% | $320.42 | 274K | $13.6M |
| 13 | UTHRUnited Therapeutics | Healthcare | 3.18% | $318.37 | 23K | $13.5M |
| 14 | TGTXTG Therapeutics | Healthcare | 3.18% | $317.98 | 216K | $13.5M |
| 15 | NBIXNeurocrine Biosciences | Healthcare | 3.03% | $302.64 | 78K | $12.9M |
of the $347B in 58 Technology ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | REGN | Regeneron Pharmaceuticals | 5.88% |
| 2 | BIIB | Biogen | 5.87% |
| 3 | GILD | Gilead Sciences | 5.80% |
| 4 | RPRX | Royalty Pharma | 5.68% |
| 5 | AMGN | Amgen | 5.38% |
| 6 | VRTX | Vertex Pharmaceuticals | 5.01% |
| 7 | ILMN | Illumina | 4.53% |
| 8 | NTRA | Natera | 4.41% |
| 9 | MRNA | Moderna | 3.81% |
| 10 | VCEL | Vericel | 3.73% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 21, 2026 | Sep 25, 2026 | $0.0187 |
| Jun 22, 2026 | Jun 26, 2026 | $0.81 |
| Mar 23, 2026 | Mar 27, 2026 | $0.0824 |
| Dec 22, 2025 | Dec 26, 2025 | $0.42 |
| Sep 22, 2025 | Sep 26, 2025 | $0.23 |
| Jun 23, 2025 | Jun 27, 2025 | $0.13 |
| Mar 24, 2025 | Mar 28, 2025 | $0.0341 |
| Jun 24, 2024 | Jun 28, 2024 | $0.0082 |
| Mar 18, 2024 | Mar 22, 2024 | $0.0242 |
| Jun 20, 2023 | Jun 23, 2023 | $0.0141 |
| Mar 23, 2020 | Mar 31, 2020 | $0.0290 |
| Sep 24, 2018 | Sep 28, 2018 | $0.0021 |